Diabetes Clinical Trial
Official title:
Effect of Vegetarian/Vegan Diets on Cardiometabolic Risk: Systematic Reviews and Meta-analyses of Randomized Controlled Dietary Trials to Provide Evidence-based Guidance for Nutrition Guidelines Development
Vegetarian and vegan diets have been shown to reduce chronic disease risk, including diabetes and cardiovascular disease, as well as several cardiometabolic risk factors. Whether vegetarian and/or vegan dietary patterns improve cardiometabolic risk factors in individuals with diabetes remains unclear. To address the uncertainties, the investigators propose to conduct a series of systematic reviews and meta-analyses of the totality of the evidence from randomized controlled trials to distinguish the effect of vegetarian and/or vegan diets on the prevention and management of diabetes. The findings generated by this proposed knowledge synthesis will help improve the health of consumers through informing evidence-based guidelines and improving health outcomes by educating healthcare providers and patients, stimulating industry innovation, and guiding future research design
Background: Vegetarian and/or vegan dietary patterns have been shown in prospective cohort
and cross-sectional studies to be associated with lower diabetes risk and all-cause
mortality. Evidence from systematic reviews and meta-analyses of controlled trials also
suggest that vegetarian diets may be beneficial for glycemic control, blood lipids, weight
loss, and blood pressure. On the contrary, evidence from previous meta-analyses of
prospective cohort studies, as well as more recent prospective cohort studies have shown
that diets higher in animal protein, specifically in red meat, are associated with an
increased incidence of T2D. The effect of following a vegetarian/vegan dietary pattern on
cardiometabolic risk factors in individuals with diabetes is less clear. Furthermore, not
all diabetes guidelines recommend following a vegetarian and/or vegan dietary pattern for
the management of diabetes or they provide a low-grade evidence rating.
Need for proposed research: High quality systematic reviews and meta-analyses of randomized
controlled trials represent the highest level of evidence to support dietary guidelines and
public health policy development. As dietary guidelines and public health policy have
shifted toward food and dietary-pattern based recommendations, there is a need for
systematic reviews and meta-analyses comparing the role of vegetarian/vegan diets in the
prevention and management of diabetes.
Objective: To improve evidence-based guidance for diabetes guidelines and public health
policy development, the investigators will conduct a series of systematic reviews and
meta-analyses of the effects of vegetarian/vegan diets on cardiometabolic risk factors in
individuals with diabetes including measures of (1) glycemic control, (2) blood lipids, (3)
adiposity and (4) blood pressure.
Design: Each systematic review and meta-analysis will be conducted according to the Cochrane
Handbook for Systematic Reviews of Interventions and reported according to the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
Data sources: MEDLINE, EMBASE, and The Cochrane Central Register of Controlled Trials
(Clinical Trials; CENTRAL) will be searched using appropriate search terms supplemented by
manual searches of references of included studies.
Study selection: Dietary randomized controlled trials conducted in humans with a follow-up
duration ≥ 3 weeks investigating the effect of vegetarian/vegan diets on measures of (1)
glycemic control, (2) blood lipids, (3) adiposity, and (4) blood pressure will be included.
Studies that are not conducted in humans, not randomized, have an acute feeding design (<3
weeks), lack a suitable control (non-isocaloric) and/or do not report viable endpoint data
will not be included.
Data extraction: Two or more investigators will independently extract relevant data and
assess risk of bias using the Cochrane Risk of Bias Tool. All disagreements will be resolved
by consensus. Standard computations and imputations will be used to derive missing variance
data.
Outcomes: The proposed syntheses will each assess a set of outcomes related to a different
area of cardiometabolic risk: (1) glycemic control (HbA1c, fasting glucose, fasting
insulin), (2) blood lipids (LDL-C, non-HDL-C, HDL-C, triglycerides), (3) adiposity (body
weight, BMI, waist circumference), (4) blood pressure (systolic and diastolic blood
pressure).
Data synthesis: Separate pooled analyses will be conducted for each area of cardiometabolic
control using the Generic Inverse Variance method. Random-effects models will be used even
in the absence of statistically significant between-study heterogeneity, as they yield more
conservative summary effect estimates in the presence of residual heterogeneity. Exceptions
will be made for the use of fixed-effects models where there is <5 included trials
irrespective of heterogeneity or small trials are being pooled with larger more precise
trials in the absence of statistically significant heterogeneity. Paired analyses will be
applied to all crossover trials. Heterogeneity will be tested by Cochran's Q statistic and
quantified by the I2 statistic. To explore sources of heterogeneity, the investigators will
conduct sensitivity analyses, in which each study is systematically removed. If there are
>=10 studies, then the investigators will also explore sources of heterogeneity by a priori
subgroup analyses by study design (parallel or crossover), follow-up duration (<12 weeks or
≥12 weeks), comparator diet, baseline measurements, risk of bias and diabetes duration.
Significant unexplained heterogeneity will be investigated by additional post hoc subgroup
analyses (e.g. age, sex, level of feeding control [metabolic, supplemented, dietary advice],
washout in crossover trials, energy balance of the background diet, composition of the
background diet [total % energy from fat, carbohydrate, protein], change in cholesterol
intake, change in glycemic index, etc.). Meta-regression analyses will assess the
significance of categorical and continuous subgroups analyses. When >=10 studies are
available, publication bias will be investigated by inspection of funnel plots and formal
testing using the Egger and Begg tests. If publication bias is suspected, then the
investigators will attempt to adjust for funnel plot asymmetry by imputing the missing study
data using the Duval and Tweedie trim and fill method.
Evidence assessment: The strength of the evidence for each outcome will be assessed using
the Grading of Recommendations Assessment, Development and Evaluation (GRADE).
Knowledge translation plan: The results will be disseminated through interactive
presentations at local, national, and international scientific meetings and publication in
high impact factor journals. Target audiences will include the public health and scientific
communities with interest in nutrition, diabetes, obesity, and cardiovascular disease.
Feedback will be incorporated and used to improve the public health message and key areas
for future research will be defined. Applicant/Co-applicant Decision Makers will network
among opinion leaders to increase awareness and participate directly as committee members in
the development of future guidelines.
Significance: The proposed project will aid in knowledge translation related to the role of
vegetarian/vegan diets in the prevention and management of diabetes, strengthening the
evidence-base for guidelines and improving health outcomes by educating healthcare providers
and patients, stimulating industry innovation, and guiding future research design.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |